Research progress on underlying mechanism of traditional Chinese medicine in treatment of immune checkpoint inhibitor-induced colitis
CSTR:
Author:
Affiliation:

(1.Faculty of Clinical Medicine of Integrated Chinese and Western Medicine, College of Integrated Chinese and Western Medicine, Shaanxi University of Chinese Medicine, Xianyang 712046, Shaanxi Province, China;2.College of Continuing Education, Shaanxi University of Chinese Medicine, Xianyang 712046, Shaanxi Province, China;3.Department of General Surgery, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang 712000, Shaanxi Province, China)

Clc Number:

Fund Project:

This work was supported by the Scientific Research Project of Affliated Hospital of Shaanxi University of Chinese Medicine(202oZJoO3).

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Tumor immunotherapy has profoundly transformed the therapeutic landscape for many advanced malignancies. However, with the increasing clinical application of immune checkpoint inhibitors (ICI), a spectrum of immune-related adverse events (irAEs) has emerged, among which ICI-induced colitis is one of the most common gastrointestinal irAEs. In severe cases, it can lead to treatment interruption and even patient death. The current mainstay treatments, glucocorticoids and biological agents, are often associated with inconsistent efficacy, significant side effects, and a risk of recurrence. In recent years, traditional Chinese medicine (TCM) has demonstrated unique advantages in treating ICI-induced colitis through its multi-target and holistic regulatory approach. In this article, based on advanced domestic and international literature, we systematically elaborated the potential mechanisms of traditional Chinese medicine and its active components in treatment of ICI-induced colitis, from the aspects of regulating regulatory T cell/T helper 17 cell balance, modulating macrophage polarization, restoring T helper 1 cell/T helper 2 cell balance, and improving gut microbiota, aiming to provide new ideas and references for alleviating irAEs and improving patient′s quality of life.

    Reference
    Related
    Cited by
Get Citation
Related Videos

Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:May 19,2025
  • Revised:
  • Adopted:
  • Online: February 03,2026
  • Published:
Article QR Code